A man who participated in a record number of medical trials after contracting HIV is being remembered as a tireless advocate ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

Bridgette J. Picou, LVN, ACLPN, presented research on the lived experiences of women living with HIV and going through ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

King Holmes, MD, PhD, an infectious diseases physician and researcher who helped create modern STI research and was a central ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Five years after the virus was declared a pandemic on March 11, 2025, worldwide deaths from Covid-19 are estimated at 19-36 ...

Research on the presence of thyroid abnormalities in HIV showed that patients with HIV are at risk for developing a variety of thyroid disorders.

The 90-day foreign aid freeze, ordered by US President Donald Trump after taking office on January 20, has upended the global supply chain for medical products to fight HIV and other diseases. It is ...